Herrera-Rodriguez J, Meijerhof T, Niesters HG, Stj. A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model. Virology 2017;515:21-28
Current influenza vaccines mainly induce antibody responses to the variable hemagglutinin proteins of the virus strains included in the vaccine. Instead, a broadly protective influenza vaccine should aim at inducing antibody- and/or cell-mediated immunity against conserved viral proteins. Vacc-FLU is a peptide based vaccine combining conserved B and T cell epitopes. Peptide selection was done using a proprietary peptide design platform technology focusing on responses to human leukocyte antigen (HLA)-restricted epitopes. Immunization of wild-type mice and mice transgenic for HLA-A2.1 with the peptide mix successfully induced both humoral and cell mediated immune responses. Partial protection from severe weight loss upon challenge was observed in both mouse strains but was stronger and observed at lower vaccine doses in transgenic mice. Our results show that the Vacc-FLU peptide mix is capable of inducing IFNγ-producing T cells and antibody-producing B cells which can protect from severe disease symptoms upon infection.
See Also:
Latest articles in those days:
- Phylogeography and gene pool analysis of highly pathogenic avian influenza H5N1 viruses reported in India from 2006 to 2021 21 hours ago
- Analysis of a diffusive epidemic model with a zero-infection zone 22 hours ago
- Quick detection of H5N1 avian influenza virus by surface enhanced Raman scattering(SERS) using aptamer capture 22 hours ago
- The critical role of RAGE in severe influenza infection: A target for control of inflammatory response in the disease 22 hours ago
- Human infection caused by avian influenza A (H10N5) virus 22 hours ago
[Go Top] [Close Window]